Arbutus Biopharma

Arbutus Biopharma

Arbutus Biopharma

Arbutus (Nasdaq: ABUS) is a biopharma company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic HBV infection.
Raised
$116M
Follow us
Alexa global traffic share
Twitter followers
02 Oct 2017
$116,000,000
Post-IPO equity